DE2460891A1 - Cyclische aminosaeuren - Google Patents
Cyclische aminosaeurenInfo
- Publication number
- DE2460891A1 DE2460891A1 DE19742460891 DE2460891A DE2460891A1 DE 2460891 A1 DE2460891 A1 DE 2460891A1 DE 19742460891 DE19742460891 DE 19742460891 DE 2460891 A DE2460891 A DE 2460891A DE 2460891 A1 DE2460891 A1 DE 2460891A1
- Authority
- DE
- Germany
- Prior art keywords
- general formula
- acid
- pharmacologically acceptable
- compound
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
C9H17NO2: | C | 63 | .13 | H | 10 | .01 | N | 8. | 18 | 0 | 18 | .69 |
Ber. : | 63 | .20 | 9 | .61 | 7. | 95 | 19 | .02 | ||||
Gef. : | ||||||||||||
C11H22C1 | NO2 | 56 | .04 |
Ber. : | C | 55 | .93 |
Gef .: | |||
C1OH | 2OC1 NO2 | 1 | H2O | 9 | .13 | Cl | 15 | .68 | - | 6 | .19 | 0 | 15 | ,88 |
Ber. | : C 53 | .12 | H | 9 | .03 | 15 | .73 | N | 6 | .16 | 15 | .77 | ||
Gef . | : 53 | .29 | ||||||||||||
Variante A:
C8H15N02 | 61 | .12 | H | 9 | .62 | N | 8 | .91 | 0 | 20 | .35 |
Ber.: C | 60 | .78 | 9 | .37 | 8 | .93 | 19 | .96 | |||
Gef .: | |||||||||||
Claims (6)
Priority Applications (23)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2460891A DE2460891C2 (de) | 1974-12-21 | 1974-12-21 | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE19752543821 DE2543821C2 (de) | 1974-12-21 | 1975-10-01 | Bestimmte Salze und Ester von 1-Aminomethyl-1-cycloalkanessigsäuren und diese Verbindungen enthaltende Arzneimittel |
MX584775U MX4691E (es) | 1974-12-21 | 1975-12-11 | Procedimiento para la preparacion de aminoacidos ciclicos |
MX584675U MX4721E (es) | 1974-12-21 | 1975-12-11 | Procedimiento para la preparacion de aminoacidos ciclicos |
IE2736/75A IE42382B1 (en) | 1974-12-21 | 1975-12-15 | Cyclic amino acids |
GB5119375A GB1465229A (en) | 1974-12-21 | 1975-12-15 | Cyclic amino acids |
CH430778A CH612665A5 (de) | 1974-12-21 | 1975-12-18 | |
CH1645175A CH612664A5 (de) | 1974-12-21 | 1975-12-18 | |
FR7538818A FR2294697A1 (fr) | 1974-12-21 | 1975-12-18 | Nouveaux acides amino cycliques |
CH430878A CH612666A5 (de) | 1974-12-21 | 1975-12-18 | |
BE6045299A BE836835A (fr) | 1974-12-21 | 1975-12-18 | Nouveaux acides amino cycliques |
FI753613A FI62282C (fi) | 1974-12-21 | 1975-12-19 | Foerfarande foer framstaellning av terapeutiskt anvaendbara cyliska aminosyror |
CA242,147A CA1052811A (en) | 1974-12-21 | 1975-12-19 | Cyclic amino-acids |
DK581475A DK147706C (da) | 1974-12-21 | 1975-12-19 | Analogifremgangsmaade til fremstilling af cycliske aminocarboxylsyrer eller farmakologisk acceptable salte deraf |
AU87741/75A AU488009B2 (en) | 1974-12-21 | 1975-12-19 | Cyclic amino-acids |
SE7514442A SE423385B (sv) | 1974-12-21 | 1975-12-19 | Forfarande for framstellning av cykloalitatiska aminosyror och estrar derav |
ES443723A ES443723A1 (es) | 1974-12-21 | 1975-12-19 | Procedimiento de preparacion de aminoacidos ciclicos. |
LU74058A LU74058A1 (de) | 1974-12-21 | 1975-12-19 | |
NLAANVRAGE7514900,A NL181006C (nl) | 1974-12-21 | 1975-12-20 | Werkwijze voor de bereiding of vervaardiging van een geneesmiddel voor de behandeling van epilepsie, duizeligheid, hypokinesis, schedeltrauma en geriatrische ziekten, alsmede werkwijze voor de bereiding van een 4-aminoboterzuur derivaat. |
JP15319475A JPS5324064B2 (de) | 1974-12-21 | 1975-12-22 | |
AT975075A AT340892B (de) | 1974-12-21 | 1975-12-22 | Verfahren zur herstellung von neuen 1-aminomethyl-1-cycloalkanessigsauren und deren estern sowie salzen |
US05/645,724 US4024175A (en) | 1974-12-21 | 1975-12-31 | Cyclic amino acids |
US05/791,677 US4087544A (en) | 1974-12-21 | 1977-04-28 | Treatment of cranial dysfunctions using novel cyclic amino acids |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2460891A DE2460891C2 (de) | 1974-12-21 | 1974-12-21 | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
DE2460891A1 true DE2460891A1 (de) | 1976-07-01 |
DE2460891C2 DE2460891C2 (de) | 1982-09-23 |
Family
ID=5934284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2460891A Expired DE2460891C2 (de) | 1974-12-21 | 1974-12-21 | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
Country Status (16)
Country | Link |
---|---|
US (1) | US4024175A (de) |
JP (1) | JPS5324064B2 (de) |
AT (1) | AT340892B (de) |
BE (1) | BE836835A (de) |
CA (1) | CA1052811A (de) |
CH (3) | CH612664A5 (de) |
DE (1) | DE2460891C2 (de) |
DK (1) | DK147706C (de) |
ES (1) | ES443723A1 (de) |
FI (1) | FI62282C (de) |
FR (1) | FR2294697A1 (de) |
GB (1) | GB1465229A (de) |
IE (1) | IE42382B1 (de) |
LU (1) | LU74058A1 (de) |
NL (1) | NL181006C (de) |
SE (1) | SE423385B (de) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0358092A1 (de) * | 1988-09-01 | 1990-03-14 | Lonza A.G. | 2-Aza-4-(alkoxycarbonyl)spiro-[4,5]decan-3-on |
EP0414274A2 (de) * | 1989-08-25 | 1991-02-27 | Gödecke Aktiengesellschaft | Verfahren zur Herstellung von 1-Aminomethyl-1-cyclohexanessigsäure |
EP0414263A2 (de) * | 1989-08-25 | 1991-02-27 | Gödecke Aktiengesellschaft | Verfahren zur Stabilisierung einer festen pharmazeutischen Zubereitungsform von cyclischen Aminosäuren. |
EP0414262A2 (de) * | 1989-08-25 | 1991-02-27 | Warner-Lambert Company | Verfahren zur Herstellung von antikonvulsanten cyclischen Aminosäureverbindungen |
US5132451A (en) * | 1989-08-25 | 1992-07-21 | Warner-Lambert Company | Process for cyclic amino acid anticonvulsant compounds |
US5319135A (en) * | 1989-08-25 | 1994-06-07 | Warner-Lambert Company | Process for cyclic amino acid anticonvulsant compounds |
ES2137137A1 (es) * | 1998-05-25 | 1999-12-01 | Medichem Sa | Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica. |
EP1468985A1 (de) * | 2003-04-18 | 2004-10-20 | FARCHEMIA S.r.l. | Verfahren zur Herstellung von Gabapentin frei von anorganischen Säureanionen |
BG65056B1 (bg) * | 1998-12-29 | 2007-01-31 | Richter Gedeon Vegyeszeti Gyar Rt. | Метод за синтез на 1-(аминометил)циклохексилоцетна киселина |
US10206890B2 (en) | 2008-09-05 | 2019-02-19 | Gruenenthal Gmbh | Pharmaceutical combination |
Families Citing this family (211)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2611690A1 (de) * | 1976-03-19 | 1977-09-22 | Goedecke Ag | Cyclische sulfonyloxyimide |
JPS5776189U (de) * | 1980-10-28 | 1982-05-11 | ||
JPS5847580U (ja) * | 1981-09-28 | 1983-03-30 | 本田技研工業株式会社 | 車両用荷物箱の取付構造 |
JPS6152583U (de) * | 1984-09-11 | 1986-04-09 | ||
JPS61139881U (de) * | 1985-02-21 | 1986-08-29 | ||
US4876279A (en) * | 1986-05-05 | 1989-10-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
US4960931A (en) * | 1988-05-02 | 1990-10-02 | Warner-Lambert Company | Gabapentin mohohydrate and a process for producing the same |
US4894476A (en) * | 1988-05-02 | 1990-01-16 | Warner-Lambert Company | Gabapentin monohydrate and a process for producing the same |
DE3928184A1 (de) * | 1989-08-25 | 1991-02-28 | Goedecke Ag | Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte |
FI905584A (fi) * | 1989-11-16 | 1991-05-17 | Lonza Ag | Foerfarande foer framstaellning av 1-(aminometyl)cyklohexanaettikssyra. |
US5157138A (en) * | 1989-11-16 | 1992-10-20 | Pfizer, Inc. | Glutaric acid derivatives and preparation thereof |
US5136091A (en) * | 1989-11-16 | 1992-08-04 | Lonza Ltd. | Process for the production of 1-(aminomethyl) cyclohexane acetic acid |
US5260467A (en) * | 1989-11-16 | 1993-11-09 | Pfizer Inc. | Glutaric acid derivatives and preparation thereof |
GB8925933D0 (en) * | 1989-11-16 | 1990-01-04 | Pfizer Ltd | Glutaric acid derivatives and preparation thereof |
US5149870A (en) * | 1989-11-16 | 1992-09-22 | Lonza Ltd. | Process for the production of 1-(aminomethyl)cyclohexane acetic acid |
US5084479A (en) * | 1990-01-02 | 1992-01-28 | Warner-Lambert Company | Novel methods for treating neurodegenerative diseases |
US5025035A (en) * | 1990-10-12 | 1991-06-18 | Warner-Lambert Company | Method of treating depression |
US5792796A (en) * | 1994-07-27 | 1998-08-11 | Warner-Lambert Company | Methods for treating anxiety and panic |
US5510381A (en) * | 1995-05-15 | 1996-04-23 | Warner-Lambert Company | Method of treatment of mania and bipolar disorder |
EA001534B1 (ru) * | 1996-02-07 | 2001-04-23 | Варнер-Ламберт Компани | Производные циклической аминокислоты или их фармацевтически приемлемые соли, фармацевтическая композиция и способ лечения депрессии, состояний паники, страха и болевых ощущений |
EP0888286B1 (de) * | 1996-03-14 | 2001-10-31 | Warner-Lambert Company | Zyklische aminosäure als pharmazeutische wirkstoffe |
NZ331142A (en) * | 1996-03-14 | 2001-04-27 | Warner Lambert Co | Bridged cyclic amino acids as pharmaceutical agents |
CN1094757C (zh) | 1996-07-24 | 2002-11-27 | 沃尼尔·朗伯公司 | 用于治疗疼痛的异丁基γ-氨基丁酸及其衍生物 |
WO1998017627A1 (en) * | 1996-10-23 | 1998-04-30 | Warner-Lambert Company | Substituted gamma aminobutyric acids as pharmaceutical agents |
IL119890A (en) * | 1996-12-24 | 2002-03-10 | Teva Pharma | Gabapentin form iii and preparation of gabapentin form ii |
US6255526B1 (en) | 1996-12-24 | 2001-07-03 | Teva Pharmaceutical Industries Ltd. | Preparation of gabapentin |
HRP980342A2 (en) * | 1997-06-25 | 1999-02-28 | Warner Lambert Co | Anti-inflammatory method |
US6329429B1 (en) | 1997-06-25 | 2001-12-11 | Warner-Lambert Company | Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases |
AU9019198A (en) | 1997-08-19 | 1999-03-08 | Warner-Lambert Company | Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants |
US6593368B2 (en) * | 1997-09-08 | 2003-07-15 | Warner-Lambert Company | Analgesic compositions comprising anti-epileptic compounds and methods of using same |
AU9318398A (en) | 1997-10-07 | 1999-04-27 | Warner-Lambert Company | Process for preparing a cyclic amino acid anticonvulsant compound |
DE69834204T2 (de) * | 1997-10-27 | 2007-03-29 | Warner-Lambert Co. Llc | Zyklische aminosäuren und deren derivate als arzneimittel |
US6984659B2 (en) * | 1997-11-18 | 2006-01-10 | Klinikum Der Albert-Ludwigs Universitaet | 2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level |
KR20010033153A (ko) | 1997-12-16 | 2001-04-25 | 로즈 암스트롱, 크리스틴 에이. 트러트웨인 | 4(3)-치환-4(3)-아미노메틸-(티오)피란 또는 -피페리딘유도체(=가바펜틴 동족체), 그의 제법 및 신경 질환 치료용도 |
IL135314A0 (en) | 1997-12-16 | 2001-05-20 | Warner Lambert Co | Novel amines as pharmaceutical agents |
CN1495160A (zh) * | 1997-12-16 | 2004-05-12 | ��ʲ | 1-取代-1-氨基甲基-环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 |
AU2463099A (en) * | 1998-01-23 | 1999-08-09 | Warner-Lambert Company | Gabapentin and its derivatives for the treatment of muscular and skeletal pain |
EP0974351A3 (de) * | 1998-04-24 | 2000-12-13 | Jouveinal | Arzneimittel zur Vorbeugung und Behandlung von Magendarmschäden |
IL139298A0 (en) | 1998-05-15 | 2001-11-25 | Warner Lambert Co | Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same |
CN100337687C (zh) * | 1998-05-15 | 2007-09-19 | 沃尼尔·朗伯公司 | 含有γ-氨基丁酸衍生物的固体组合物及其制备方法 |
BR9910697A (pt) | 1998-05-26 | 2001-01-30 | Warner Lambert Co | Compostos aminoácidos comprimidos estruturalmente tendo afinidade à subunidade alfa2delta de um canal de cálcio |
ITMI981535A1 (it) * | 1998-07-03 | 2000-01-03 | Zambon Spa | Processo per la preparazione di gabapentina |
US20030045500A1 (en) * | 1998-07-09 | 2003-03-06 | Leslie Magnus | Pharmaceutical composition containing GABA analogs and an antiviral agent to treat shingles |
FR2781793B1 (fr) | 1998-08-03 | 2001-07-20 | Prographarm Lab | Procede de fabrication de granules de gabapentine enrobes |
IT1311984B1 (it) | 1999-03-26 | 2002-03-22 | Bioindustria Lab Italiano Medi | Procedimento per la preparzione di gabapentin. |
ATE303162T1 (de) * | 1999-04-09 | 2005-09-15 | Euro Celtique Sa | Natrium kanalblocker zusammensetzungen und deren verwendung |
US6710190B1 (en) * | 1999-05-28 | 2004-03-23 | Warner-Lambert Company | 3-heteroarylalkyl substituted gaba analogs |
DE60017730T2 (de) * | 1999-05-28 | 2005-06-23 | Warner-Lambert Co. Llc | 3-heteroarylalkyl-substituierte gaba-analoga |
US7164034B2 (en) * | 1999-06-10 | 2007-01-16 | Pfizer Inc. | Alpha2delta ligands for fibromyalgia and other disorders |
EP1192125B9 (de) * | 1999-06-10 | 2009-09-16 | Warner-Lambert Company LLC | Mono-substituierte 3-propyl-gamma-aminobuttersäure |
US20080207755A1 (en) * | 2000-05-31 | 2008-08-28 | Pfizer Inc | Alpha 2 Delta Ligands For Fibromyalgia and Other Disorders |
US6294198B1 (en) | 1999-08-24 | 2001-09-25 | Purepac Pharmaceutical Co. | Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same |
HN2000000224A (es) | 1999-10-20 | 2001-04-11 | Warner Lambert Co | Aminoacidos biciclicos como agentes farmaceuticos |
GB2362646A (en) * | 2000-05-26 | 2001-11-28 | Warner Lambert Co | Cyclic amino acid derivatives useful as pharmaceutical agents |
EP1384473A1 (de) * | 2000-06-16 | 2004-01-28 | Teva Pharmaceutical Industries Ltd. | Stabiles Gabapentin das mehr als 20 ppm Chlor enthält |
CZ200339A3 (cs) * | 2000-06-16 | 2003-06-18 | Teva Pharmaceutical Industries Ltd. | Stabilní gabapentin vykazující neutrální pH |
EP1289364B1 (de) | 2000-06-16 | 2003-12-10 | Teva Pharmaceutical Industries Ltd. | Stabiles gabapentin, das mehr als 20 ppm chlor enthält |
KR100785182B1 (ko) * | 2000-06-26 | 2007-12-11 | 워너-램버트 캄파니 엘엘씨 | 수면 장애를 위한 가바펜틴 유사체 |
GB2364049A (en) * | 2000-06-28 | 2002-01-16 | Warner Lambert Co | Cyclic ketones and their use in the synthesis of amino acids |
ES2252310T3 (es) * | 2000-09-14 | 2006-05-16 | Grunenthal Gmbh | Beta-tioaminoacidos. |
EP1361847A2 (de) * | 2000-10-06 | 2003-11-19 | Xenoport, Inc. | Gallensäurekonjugate zur bereitstellung anhaltender systemischer arneimittelkonzentrationen |
EP1343805A4 (de) * | 2000-10-06 | 2005-07-20 | Xenoport Inc | Von gallensäuren abgeleitete verbindungen für die bereitstellung anhaltender systemischer konzentrationen von arzneimitteln nach oraler verabreichung |
US6620829B2 (en) * | 2000-10-17 | 2003-09-16 | Warner-Lambert Company | Method of treating noninflammatory cartilage damage |
IT1319234B1 (it) * | 2000-10-23 | 2003-09-26 | Zambon Spa | Processo di preparazione di gabapentina. |
GB2368579A (en) * | 2000-10-31 | 2002-05-08 | Parke Davis & Co Ltd | Azole pharmaceutical agents |
HUP0303352A3 (en) | 2000-11-02 | 2005-04-28 | Teva Pharma | Improved process for production of gabapentin intermediate |
DE60106968T2 (de) * | 2000-11-30 | 2005-11-03 | Pfizer Products Inc., Groton | Kombination von gaba agonisten und sorbitol dehydrogenase inhibitoren |
MXPA03004871A (es) * | 2000-11-30 | 2003-08-19 | Pfizer Prod Inc | Combinacion de agonistas de gaba e inhibidores de aldosa-reductasa. |
IT1319674B1 (it) * | 2000-12-01 | 2003-10-23 | Erregierre Spa | Processo per la preparazione dell'acido1-(aminometil)cicloesanacetico. |
EP1373186A1 (de) * | 2001-03-16 | 2004-01-02 | Solchem Italiana S.p.A | Verfahren zur herstellung von zyklischen aminosäuren |
ITMI20011132A1 (it) | 2001-05-29 | 2002-11-29 | Procos Spa | Procedimento per la preparazione dell'acido 1-amminometil-1-cicloesanacetico |
US7186855B2 (en) * | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
ES2296956T5 (es) * | 2001-06-11 | 2011-07-12 | Xenoport, Inc. | Profármacos de análogos de gaba, composiciones y sus usos. |
EP1412324A4 (de) * | 2001-06-11 | 2004-09-29 | Xenoport Inc | Aminosäurekonjugate, die anhaltende systemische konzentrationen von gaba-analoga ergeben |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US6818787B2 (en) * | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7232924B2 (en) * | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
IL144066A0 (en) * | 2001-06-28 | 2002-04-21 | Bromine Compounds Ltd | Process for the preparation of 1,1-cyclohexane diacetic monoamide |
ITMI20011772A1 (it) | 2001-08-10 | 2003-02-10 | A M S A Anonima Materie Sint E | Processo per la preparazione della 2,5-bis-(2,2,2-trifluoroetossi)-n-(2-piperidilmetil)-benzamide(flecainide) |
AU2002333374B2 (en) | 2001-09-03 | 2007-03-22 | Newron Pharmaceuticals S.P.A. | Pharmaceutical composition comprising gabapentin or an analogue thereof and an (alpha)- aminoamide and its analgesic use |
US6800782B2 (en) * | 2001-10-09 | 2004-10-05 | Warner-Lambert Co. | Anhydrous crystalline forms of gabapentin |
US20060159743A1 (en) * | 2001-10-25 | 2006-07-20 | Depomed, Inc. | Methods of treating non-nociceptive pain states with gastric retentive gabapentin |
TWI312285B (en) | 2001-10-25 | 2009-07-21 | Depomed Inc | Methods of treatment using a gastric retained gabapentin dosage |
US7612112B2 (en) * | 2001-10-25 | 2009-11-03 | Depomed, Inc. | Methods of treatment using a gastric retained gabapentin dosage |
US20070184104A1 (en) * | 2001-10-25 | 2007-08-09 | Depomed, Inc. | Gastric retentive gabapentin dosage forms and methods for using same |
ITMI20012750A1 (it) | 2001-12-21 | 2003-06-21 | Procos Spa | Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura |
US20030119908A1 (en) * | 2001-12-21 | 2003-06-26 | Zambon Group S.P.A. | Stable gabapentin compositions |
JP2005521664A (ja) * | 2002-01-31 | 2005-07-21 | ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー | 耳鳴を治療するためのアルファ2デルタ・リガンド |
US6682759B2 (en) | 2002-02-01 | 2004-01-27 | Depomed, Inc. | Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs |
AU2002316231A1 (en) * | 2002-02-19 | 2003-09-29 | Xenoport, Inc. | Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof |
WO2003080588A1 (en) * | 2002-03-20 | 2003-10-02 | Xenoport | Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof |
AU2003262383A1 (en) * | 2002-04-16 | 2003-11-03 | Taro Pharmaceutical Industries Ltd. | Process for preparing gabapentin |
EP1549323A2 (de) * | 2002-05-07 | 2005-07-06 | A & D Bioscience, Inc. | Konjugate mit einem wirkstoff für das zentrale nervensystem |
WO2003099338A2 (en) * | 2002-05-17 | 2003-12-04 | Xenoport, Inc. | Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
WO2004002462A2 (en) * | 2002-06-27 | 2004-01-08 | Warner-Lambert Company Llc | Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder |
CA2395931A1 (en) * | 2002-08-07 | 2004-02-07 | Bernard Charles Sherman | Solid compositions comprising gabapentin having improved stability |
US7053122B2 (en) * | 2002-08-09 | 2006-05-30 | Pfizer Inc | Therapeutic use of aryl amino acid derivatives |
US20040092591A1 (en) * | 2002-08-15 | 2004-05-13 | Blakemore David Clive | Therapeutic use of fused bicyclic or tricyclic amino acids |
US20040092522A1 (en) * | 2002-08-15 | 2004-05-13 | Field Mark John | Synergistic combinations |
US7419981B2 (en) * | 2002-08-15 | 2008-09-02 | Pfizer Inc. | Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor |
US20040092498A1 (en) * | 2002-08-16 | 2004-05-13 | David Blakemore | Substituted glycine derivatives for use as medicaments |
ITMI20022071A1 (it) * | 2002-10-01 | 2004-04-02 | Erregierre Spa | Processo di sintesi dell'acido 1-(aminometil)cicloesanacetico cloridato. |
US7659305B2 (en) * | 2002-10-31 | 2010-02-09 | Pfizer Inc. | Therapeutic proline derivatives |
WO2004046084A1 (en) * | 2002-11-18 | 2004-06-03 | Nicholas Piramal India Limited | Improved process for preparation of gabapentin |
US7632953B2 (en) * | 2002-11-20 | 2009-12-15 | Hikal Limited | Process for the preparation of gabalactam |
US7060727B2 (en) * | 2002-12-11 | 2006-06-13 | Xenoport, Inc. | Prodrugs of fused GABA analogs, pharmaceutical compositions and uses thereof |
AU2003297909A1 (en) * | 2002-12-11 | 2004-06-30 | Xenoport, Inc. | Orally administered dosage forms of fused gaba analog prodrugs having reduced toxicity |
CA2508297A1 (en) * | 2002-12-13 | 2004-07-01 | Warner-Lambert Company Llc | Pregabalin and derivates thereof for the treatment of fibromyalgia and other related disorders |
WO2004054566A1 (en) | 2002-12-13 | 2004-07-01 | Warner-Lambert Company Llc | Pregabalin derivatives for the treatment of fibromyalgia and other disorders |
DE60332387D1 (de) | 2002-12-13 | 2010-06-10 | Warner Lambert Co | Alpha-2-delta-ligand zur behandlung vonsymptomen der unteren harnwege |
US20040180958A1 (en) * | 2002-12-13 | 2004-09-16 | Taylor Charles Price | Method of treatment |
JP2006511605A (ja) * | 2002-12-13 | 2006-04-06 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 線維筋痛及び他の関連障害のためのガバペンチン類縁体 |
CA2451267A1 (en) * | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
GB0301143D0 (en) * | 2003-01-17 | 2003-02-19 | Amedis Pharm Ltd | Compounds and their use |
AU2004205523A1 (en) * | 2003-01-22 | 2004-08-05 | Warner-Lambert Company Llc | Cyclopropyl beta-amino acid derivatives |
BRPI0408110A (pt) * | 2003-03-07 | 2006-03-01 | Warner Lambert Co | derivados de beta-aminoácido substituìdos com tetrazol e oxadiazolona |
EP1628656B1 (de) * | 2003-03-25 | 2008-10-15 | Kiel Laboratories, Inc. | Gabapentintannat in flüssigen und/oder halbfesten dosierformen |
EP1622603A4 (de) * | 2003-03-25 | 2010-03-24 | Kiel Lab Inc | Phenolsäuresalze von gabapentin in festen dosierformen und anwendungsverfahren |
WO2004093866A1 (en) * | 2003-03-25 | 2004-11-04 | Kiel Laboratories, Inc. | Process for preparing phenolic acid salts of gabapentin |
EP1608357A4 (de) * | 2003-03-31 | 2008-03-26 | Xenoport Inc | Behandlung oder prävention von hitzewallungen unter verwendung von prodrugs von gaba-analoga |
US20040214893A1 (en) * | 2003-04-11 | 2004-10-28 | Matthew Peterson | Gabapentin compositions |
EP1615875A2 (de) * | 2003-04-21 | 2006-01-18 | Matrix Laboratories Limited | Verfahren zur herstellung von gabapentin form-ii |
MXPA05012317A (es) * | 2003-05-16 | 2006-01-30 | Pfizer Prod Inc | Combinaciones terapeuticas de agentes antipsicoticos atipicos con agentes moduladores del gaba anticonvulsivos o benzodiazepinas. |
CA2528388A1 (en) * | 2003-06-19 | 2004-12-23 | Pfizer Products Inc. | Biocatalytic preparation of 1-cyanocyclohexaneacetic acid |
US7169812B2 (en) * | 2003-07-01 | 2007-01-30 | Medtronic, Inc. | Process for producing injectable gabapentin compositions |
WO2005002585A1 (en) * | 2003-07-02 | 2005-01-13 | Warner-Lambert Company Llc | Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor |
US20050013863A1 (en) | 2003-07-18 | 2005-01-20 | Depomed, Inc., A Corporation Of The State Of California | Dual drug dosage forms with improved separation of drugs |
WO2005046566A2 (en) * | 2003-08-04 | 2005-05-26 | Sun Pharmaceutical Industries Limited | Stable gabapentin containing composition |
US20050043407A1 (en) * | 2003-08-22 | 2005-02-24 | Pfizer Inc | Pharmaceutical composition for the prevention and treatment of addiction in a mammal |
KR20060119971A (ko) * | 2003-09-11 | 2006-11-24 | 제노포트 인코포레이티드 | Gaba 유사체의 전구약물을 이용한 요실금의 치료및/또는 예방 |
MXPA06002619A (es) * | 2003-09-12 | 2006-06-05 | Warner Lambert Co | Procedimiento para el tratamiento de trastornos de depresion y ansiedad mediante terapia de combinacion. |
CN1849153A (zh) | 2003-09-12 | 2006-10-18 | 辉瑞大药厂 | 含有α-2-δ配体和5-羟色胺/去甲肾上腺素重摄取抑制剂的组合物 |
CN1871021B (zh) * | 2003-09-17 | 2010-07-28 | 什诺波特有限公司 | 用gaba类似物的前药治疗或预防多动腿综合征 |
SI1677767T1 (sl) | 2003-10-14 | 2011-11-30 | Xenoport Inc | Kristalinična oblika analoga gama-aminomaslene kisline |
ITMI20032165A1 (it) * | 2003-11-11 | 2005-05-12 | Zambon Spa | Processo di preparazione di gabapentina |
DK1691811T3 (da) | 2003-12-11 | 2014-10-20 | Sunovion Pharmaceuticals Inc | Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression |
CA2553291A1 (en) * | 2004-01-29 | 2005-09-09 | Pfizer Products Inc. | Combination of .gamma.-aminobutyric acid modulators and 5-ht1b receptor antagonists |
US20050187295A1 (en) * | 2004-02-19 | 2005-08-25 | Surendra Kalyan | Processes for the preparation of gabapentin |
EP1763503A1 (de) * | 2004-03-17 | 2007-03-21 | Hikal Limited | 4-t-butylgabapentin und dessen synthese |
ITMI20040579A1 (it) * | 2004-03-25 | 2004-06-25 | Zambon Spa | Processo di preparazione di gabapentina |
EP1737473A4 (de) * | 2004-04-19 | 2009-08-26 | Noven Therapeutics Llc | Lithium-kombinationen und relevante verwendungen |
WO2006000903A2 (en) * | 2004-06-09 | 2006-01-05 | Pfizer Limited | Use of reboxetine for the treatment of pain |
GB0416228D0 (en) * | 2004-07-20 | 2004-08-25 | Sandoz Ind Products S A | Process for the preparation of gabapentin |
GB0419849D0 (en) * | 2004-09-07 | 2004-10-13 | Pfizer Ltd | Pharmaceutical combination |
SI1809271T1 (sl) * | 2004-09-10 | 2010-10-29 | Newron Pharm Spa | Uporaba (R)-(halobenziloksi) benzilamino propanamidov kot selektivnih modulatorjev natrijevih in/ali kalcijevih kanalov |
BRPI0517227B8 (pt) * | 2004-11-04 | 2021-05-25 | Xenoport Inc | comprimido oral de liberação prolongada do ácido 1-{[alfa-isobutanoiloxietoxi)carbonil]amino metil}-1-cicloexano acético, e, uso do comprimido |
EP2258359A3 (de) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin |
EP2275095A3 (de) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenese durch modulation des Muscarinrezeptors |
CA2623803A1 (en) | 2005-09-23 | 2007-03-29 | Janssen Pharmaceutica N.V. | Tetrahydro-cyclopentyl pyrazole cannabinoid modulators |
SI1937259T1 (sl) * | 2005-09-23 | 2012-02-29 | Janssen Pharmaceutica Nv | Heksahidro-cikloheptapirazol kanabionidni modulatorji |
US8378117B2 (en) * | 2005-09-23 | 2013-02-19 | Janssen Pharmaceutica N.V. | Hexahydro-cycloheptapyrazole cannabinoid modulators |
US7825151B2 (en) * | 2005-09-23 | 2010-11-02 | Janssen Pharmaceutica Nv | Hexahydro-cyclooctyl pyrazole cannabinoid modulators |
US8378096B2 (en) * | 2005-09-23 | 2013-02-19 | Janssen Pharmaceutica N.V. | Hexahydro-cycloheptapyrazole cannabinoid modulators |
MY148863A (en) * | 2005-09-23 | 2013-06-14 | Janssen Pharmaceutica Nv | Hexahydro-cyclooctyl pyrazole cannabinoid modulators |
EP2377530A3 (de) | 2005-10-21 | 2012-06-20 | Braincells, Inc. | Modulation von Neurogenese durch PDE-Hemmung |
EP2314289A1 (de) | 2005-10-31 | 2011-04-27 | Braincells, Inc. | Gaba-rezeptor-vermittelte modulation von neurogenese |
US20070117858A1 (en) * | 2005-11-23 | 2007-05-24 | Mingde Xia | Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators |
US20090176882A1 (en) | 2008-12-09 | 2009-07-09 | Depomed, Inc. | Gastric retentive gabapentin dosage forms and methods for using same |
WO2007092456A2 (en) * | 2006-02-03 | 2007-08-16 | Rolls-Royce Corporation | Gas turbine engine fuel system with fuel metering valve |
EP1820502A1 (de) | 2006-02-10 | 2007-08-22 | Laboratorios Del Dr. Esteve, S.A. | Wirkstoffzusammensetzungen enthaltend Azolycarbinolderivate |
US7795294B2 (en) * | 2006-02-14 | 2010-09-14 | Janssen Pharmaceutica N.V. | Tetrahydro-2H-indazole pyrazole cannabinoid modulators |
EP1993529A1 (de) * | 2006-03-06 | 2008-11-26 | Pfizer Products Inc. | Alpha-2-delta-liganden für nicht-restorativen schlaf |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
WO2007112402A1 (en) * | 2006-03-27 | 2007-10-04 | Janssen Pharmaceutica N.V. | Tetrahydro-1h-1,2,6-triaza-azulene cannabinoid modulators |
US20070254911A1 (en) * | 2006-03-27 | 2007-11-01 | Mingde Xia | Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators |
WO2007134077A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
CA2651813A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
US7442834B2 (en) * | 2006-06-12 | 2008-10-28 | Zhejiang Chiral Medicine Chemicals Co., Ltd. | Process suitable for industrial scale production of gabapentin |
ES2439242T3 (es) * | 2006-06-30 | 2014-01-22 | Zach System S.P.A. | Procedimiento para preparar gabapentina |
AU2007292848A1 (en) | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
MX2009006080A (es) * | 2006-12-08 | 2009-07-14 | Xenoport Inc | Uso de profarmacos de analogos de gaba para el tratamiento de enfermedades. |
RS51940B (en) | 2006-12-22 | 2012-02-29 | Recordati Ireland Limited | Combined TH2δ LIGANAD THERAPY AND NSAID FOR LOWER URINARY TRACT DISORDERS |
CN101631768A (zh) * | 2007-03-15 | 2010-01-20 | 太阳医药高级研究有限公司 | 新型前药 |
US20090041806A1 (en) * | 2007-06-15 | 2009-02-12 | Xenoport, Inc. | Use of prodrugs of gaba analogs, antispasticity agents, and prodrugs of gaba b receptor agonists for treating spasticity |
US7943653B2 (en) * | 2007-08-13 | 2011-05-17 | Janssen Pharmaceutica N.V. | Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
US20090062392A1 (en) * | 2007-08-29 | 2009-03-05 | Protia, Llc | Deuterium-enriched gabapentin |
TW200936123A (en) * | 2007-11-06 | 2009-09-01 | Xenoport Inc | Use of prodrugs of GABAb agonists for treating neuropathic and musculoskeletal pain |
US7868043B2 (en) | 2008-01-25 | 2011-01-11 | Xenoport, Inc. | Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use |
TWI369202B (en) * | 2008-01-25 | 2012-08-01 | Xenoport Inc | Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs |
US7872046B2 (en) * | 2008-01-25 | 2011-01-18 | Xenoport, Inc. | Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use |
EP2116539A1 (de) | 2008-04-25 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | 1-Aryl-3-Amino-alkoxy-pyrazole als Sigma-Liganden zur Verbesserung der analgetischen Wirkung von Opioiden und zur Schwächung der Abhängigkeit davon |
CN102216257B (zh) | 2008-10-08 | 2015-11-25 | 凯飞药业公司 | Gaba偶联物及其使用方法 |
EP2400989B1 (de) | 2009-02-24 | 2016-08-10 | Nektar Therapeutics | Gabapentin-peg konjugate |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
US20110124705A1 (en) * | 2009-11-24 | 2011-05-26 | Xenoport, Inc. | Prodrugs of alpha-2-delta ligands, pharmaceutical compositions and uses thereof |
US20110130454A1 (en) * | 2009-11-24 | 2011-06-02 | Xenoport, Inc. | Prodrugs of gamma-amino acid, alpha-2-delta ligands, pharmaceutical compositions and uses thereof |
JP5815552B2 (ja) | 2009-12-08 | 2015-11-17 | ケース ウェスタン リザーブ ユニバーシティCase Westernreserve University | 眼疾患を治療する化合物および方法 |
EP2353591A1 (de) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma-Liganden zur Verstärkung der analgesischen Wirkung von Opioden und Opiaten bei postoperativem Schmerz und zur Schwächung der Abhängigkeit davon |
EP2368872A1 (de) | 2010-03-25 | 2011-09-28 | Serichim S.r.l. | Verfahren zur Herstellung von Gabapentin |
EP2388005A1 (de) | 2010-05-21 | 2011-11-23 | Laboratorios Del. Dr. Esteve, S.A. | Sigma-Liganden zur Vorbeugung und/oder Behandlung von Erbrechen infolge von Chemotherapie oder Strahlentherapie |
IN2012MN02923A (de) | 2010-06-01 | 2015-06-05 | Rubicon Res Private Ltd | |
US8431739B2 (en) | 2010-06-14 | 2013-04-30 | Divi's Laboratories, Ltd. | Process for the preparation of gabapentin |
MX2013000946A (es) | 2010-07-30 | 2013-02-27 | Toray Industries | Agente terapeutico o agente profilactico para el dolor neuropatico. |
EP2415471A1 (de) | 2010-08-03 | 2012-02-08 | Laboratorios Del. Dr. Esteve, S.A. | Verwendung von Sigmaliganden bei opioidinduzierter Hyperalgesie |
JP2013216580A (ja) * | 2010-08-06 | 2013-10-24 | Kyorin Pharmaceutical Co Ltd | ビシクロ[2.2.2]オクチルアミン誘導体の製造方法 |
EP2524694A1 (de) | 2011-05-19 | 2012-11-21 | Laboratorios Del. Dr. Esteve, S.A. | Verwendung von Sigmaliganden bei Schmerz im Zusammenhang mit Typ-2-Diabetes |
EP2530072A1 (de) | 2011-06-03 | 2012-12-05 | Lacer, S.A. | Neue Verbindungen, deren Synthese und Verwendung bei der Schmerzbehandlung |
US9066853B2 (en) | 2013-01-15 | 2015-06-30 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable fiber |
ITMI20131757A1 (it) | 2013-10-22 | 2015-04-23 | Zach System Spa | Processo di preparazione di gabapentina |
JPWO2015064453A1 (ja) | 2013-11-01 | 2017-03-09 | 株式会社糖鎖工学研究所 | チオール基を有するd−体またはl−体アミノ酸誘導体の製造方法 |
TN2016000228A1 (en) | 2013-12-17 | 2017-10-06 | Esteve Labor Dr | SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS. |
TN2016000229A1 (en) | 2013-12-17 | 2017-10-06 | Esteve Labor Dr | Gabapentinoids and sigma receptor ligands combinations. |
WO2015144825A1 (en) | 2014-03-27 | 2015-10-01 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Oral liquid pharmaceutical solution of gabapentin |
PL3554490T3 (pl) | 2016-12-16 | 2022-05-30 | Idorsia Pharmaceuticals Ltd | Kombinacja farmaceutyczna zawierająca bloker kanału wapniowego typu T |
WO2020009560A1 (es) | 2018-07-04 | 2020-01-09 | AMÉZCUA AMÉZCUA, Federico | Combinación farmacéutica sinérgica del enantiómero activo s-ketorolaco y gabapentina para el tratamiento del dolor neuropático |
US10399926B1 (en) | 2018-08-01 | 2019-09-03 | Divi's Laboratories Ltd. | Process for the preparation of gabapentin |
MX2021003653A (es) | 2018-10-11 | 2021-06-23 | Sanifit Therapeutics S A | Inositol fosfatos para el tratamiento de calcificacion ectopica. |
US20220296548A1 (en) | 2019-10-25 | 2022-09-22 | Kyoto University | Preventative or therapeutic agent for tauopathy |
EP4015494A1 (de) | 2020-12-15 | 2022-06-22 | Sanifit Therapeutics S.A. | Verfahren zur herstellung von löslichen salzen von inositolphosphaten |
GB2625579A (en) | 2022-12-21 | 2024-06-26 | Novumgen Ltd | An orally disintegrating tablet containing gabapentin or pharmaceutically acceptable salts thereof and the process of preparing the same |
-
1974
- 1974-12-21 DE DE2460891A patent/DE2460891C2/de not_active Expired
-
1975
- 1975-12-15 GB GB5119375A patent/GB1465229A/en not_active Expired
- 1975-12-15 IE IE2736/75A patent/IE42382B1/en unknown
- 1975-12-18 CH CH1645175A patent/CH612664A5/xx not_active IP Right Cessation
- 1975-12-18 CH CH430878A patent/CH612666A5/xx active Protection Beyond IP Right Term
- 1975-12-18 BE BE6045299A patent/BE836835A/xx not_active IP Right Cessation
- 1975-12-18 CH CH430778A patent/CH612665A5/xx not_active IP Right Cessation
- 1975-12-18 FR FR7538818A patent/FR2294697A1/fr active Granted
- 1975-12-19 SE SE7514442A patent/SE423385B/xx active Protection Beyond IP Right Term
- 1975-12-19 LU LU74058A patent/LU74058A1/xx unknown
- 1975-12-19 CA CA242,147A patent/CA1052811A/en not_active Expired
- 1975-12-19 ES ES443723A patent/ES443723A1/es not_active Expired
- 1975-12-19 DK DK581475A patent/DK147706C/da not_active IP Right Cessation
- 1975-12-19 FI FI753613A patent/FI62282C/fi not_active IP Right Cessation
- 1975-12-20 NL NLAANVRAGE7514900,A patent/NL181006C/xx not_active IP Right Cessation
- 1975-12-22 AT AT975075A patent/AT340892B/de active Protection Beyond IP Right Term
- 1975-12-22 JP JP15319475A patent/JPS5324064B2/ja not_active Expired
- 1975-12-31 US US05/645,724 patent/US4024175A/en not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
NICHTS-ERMITTELT * |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0358092A1 (de) * | 1988-09-01 | 1990-03-14 | Lonza A.G. | 2-Aza-4-(alkoxycarbonyl)spiro-[4,5]decan-3-on |
US5319135A (en) * | 1989-08-25 | 1994-06-07 | Warner-Lambert Company | Process for cyclic amino acid anticonvulsant compounds |
US5132451A (en) * | 1989-08-25 | 1992-07-21 | Warner-Lambert Company | Process for cyclic amino acid anticonvulsant compounds |
EP0414262A2 (de) * | 1989-08-25 | 1991-02-27 | Warner-Lambert Company | Verfahren zur Herstellung von antikonvulsanten cyclischen Aminosäureverbindungen |
EP0414274A3 (en) * | 1989-08-25 | 1991-05-15 | Goedecke Aktiengesellschaft | Process for the preparation of 1 aminomethyl-1.cyclohexanacetic acid |
US5362883A (en) * | 1989-08-25 | 1994-11-08 | Warner-Lambert Company | Process for cyclic amino acid anticonvulsant compounds |
EP0414262A3 (en) * | 1989-08-25 | 1991-06-05 | Warner-Lambert Company | Process for the preparation of cyclic amino anticonvulsant compounds |
EP0414263A2 (de) * | 1989-08-25 | 1991-02-27 | Gödecke Aktiengesellschaft | Verfahren zur Stabilisierung einer festen pharmazeutischen Zubereitungsform von cyclischen Aminosäuren. |
EP0414274A2 (de) * | 1989-08-25 | 1991-02-27 | Gödecke Aktiengesellschaft | Verfahren zur Herstellung von 1-Aminomethyl-1-cyclohexanessigsäure |
EP0414263A3 (en) * | 1989-08-25 | 1991-06-05 | Goedecke Aktiengesellschaft | Lactamfree cyclic aminoacids |
US5693845A (en) * | 1989-08-25 | 1997-12-02 | Warner-Lambert Company | Cyanocycloalkylacetic acid and ester intermediates for preparing cyclic amino acid anticonvulsant compounds |
ES2137137A1 (es) * | 1998-05-25 | 1999-12-01 | Medichem Sa | Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica. |
WO1999061408A1 (es) * | 1998-05-25 | 1999-12-02 | Medichem, S.A. | Polimorfo de gabapentina no hidratada, procedimiento para su obtención y su utilización para la obtención de gabapentina de calidad farmacéutica |
BG65056B1 (bg) * | 1998-12-29 | 2007-01-31 | Richter Gedeon Vegyeszeti Gyar Rt. | Метод за синтез на 1-(аминометил)циклохексилоцетна киселина |
CZ301922B6 (cs) * | 1998-12-29 | 2010-07-28 | Richter Gedeon Vegyészeti Gyár Rt. | Zpusob prípravy kyseliny 1-(aminomethyl)cyklohexyloctové a meziprodukt pri její príprave |
EP1468985A1 (de) * | 2003-04-18 | 2004-10-20 | FARCHEMIA S.r.l. | Verfahren zur Herstellung von Gabapentin frei von anorganischen Säureanionen |
US10206890B2 (en) | 2008-09-05 | 2019-02-19 | Gruenenthal Gmbh | Pharmaceutical combination |
Also Published As
Publication number | Publication date |
---|---|
AT340892B (de) | 1978-01-10 |
JPS5324064B2 (de) | 1978-07-18 |
DK581475A (da) | 1976-01-22 |
GB1465229A (en) | 1977-02-23 |
SE423385B (sv) | 1982-05-03 |
ES443723A1 (es) | 1977-04-16 |
FI753613A (de) | 1976-06-22 |
FI62282C (fi) | 1982-12-10 |
DE2460891C2 (de) | 1982-09-23 |
JPS5188940A (de) | 1976-08-04 |
CA1052811A (en) | 1979-04-17 |
FI62282B (fi) | 1982-08-31 |
IE42382L (en) | 1976-06-21 |
NL181006C (nl) | 1987-06-01 |
DK147706C (da) | 1985-05-13 |
AU8774175A (en) | 1977-06-23 |
CH612664A5 (de) | 1979-08-15 |
NL181006B (nl) | 1987-01-02 |
NL7514900A (nl) | 1976-06-23 |
US4024175A (en) | 1977-05-17 |
BE836835A (fr) | 1976-06-18 |
IE42382B1 (en) | 1980-07-30 |
FR2294697B1 (de) | 1978-07-28 |
CH612666A5 (de) | 1979-08-15 |
FR2294697A1 (fr) | 1976-07-16 |
DK147706B (da) | 1984-11-19 |
SE7514442L (sv) | 1976-06-22 |
CH612665A5 (de) | 1979-08-15 |
LU74058A1 (de) | 1976-07-20 |
ATA975075A (de) | 1977-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2460891A1 (de) | Cyclische aminosaeuren | |
DE2635853A1 (de) | Pyrrolidin-2-on-derivate, verfahren zu ihrer herstellung und sie enthaltendes arzneimittel | |
DE1645971A1 (de) | Verfahren zur Herstellung von therapeutisch wertvollen (Indazol-3-yl)-oxyalkansaeuren | |
DE1944121A1 (de) | Neue Glyoxylsaeurederivate,Verfahren zu ihrer Herstellung und Verwendung als Pharmazeutika | |
DE2051269A1 (de) | Verfahren zur Herstellung von 3 Propionyl salicylsäure beziehungsweise ihren Derivaten | |
DE1959898A1 (de) | ortho-substituierte Phenaethylamine und Verfahren zu ihrer Herstellung | |
DE2446100C3 (de) | Phenoxyalkancarbonsäureamide von Thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und Arzneimittel | |
DE2543821C2 (de) | Bestimmte Salze und Ester von 1-Aminomethyl-1-cycloalkanessigsäuren und diese Verbindungen enthaltende Arzneimittel | |
AT354644B (de) | Verfahren zur herstellung von neuen salzen von alkaloidderivaten von thiophosphorsaeure | |
CH610330A5 (en) | Process for the preparation of novel ergopeptins | |
DE2520131C3 (de) | 1,1,-Disubstituierte Octahydro-indolo[2,3-a]chinolizine und verfahren zu deren Herstellung | |
EP0387677B1 (de) | Thienylessigsäurederivate, Verfahren zu ihrer Herstellung ihre Verwendung sowie diese enthaltende Arzneimittel und deren Herstellung | |
DE1227893B (de) | Verfahren zur Herstellung von Glycyrrhetinsaeurederivaten | |
DE2727629A1 (de) | 1-p-chlorbenzoyl-5-methoxy-2-methyl- 3-indolyl-essigsaeure-2'-phenyl-2'-carbonsaeureaethylester, verfahren zu seiner herstellung und pharmazeutische mittel | |
DE2236005C3 (de) | Dibenzo- eckige Klammer auf d,f eckige Klammer zu -dioxepin- eckige Klammer auf 1,3 eckige Klammer zu -derivate und deren pharmakologisch verträgliche Salze, sowie Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
DD246299A5 (de) | Verfahren zur herstellung n-substituierter anziridin-2-carbonsaeurederivaten | |
DE522064C (de) | Verfahren zur Darstellung von Monoalkoxyaminobenzoesaeurealkaminestern | |
DE968561C (de) | Verfahren zur Herstellung von am Aminostickstoff substituierten Monoaminoacylaniliden | |
DE1620190C (de) | 4-(2-Carbo-alpha-glyceryloxyphenylamino)-8-chlorchinolin, seine Salze und ein Verfahren zu ihrer Herstellung | |
DE1900948C (de) | Cis- und trans-2-Methyl-5-(3, 4, S-trimethoxybenzamidoJ-decahydroisochinolin | |
DE1768818C3 (de) | Anthranilsäureamide und Verfahren zu deren Herstellung | |
DE2500919C3 (de) | 5-(l-Allyl-2-pyrrolidinylmethylaminocarbonyl)-6-methoxy-benzotriazol sowie seine pharmazeutisch verträglichen Additionssalze mit Säuren | |
AT210886B (de) | Verfahren zur Herstellung von neuen, basisch substituierten Diphenylcarbinolestern und deren Salzen | |
DE1595891C3 (de) | 6-(ß-Dimethylaminopropyl)-pyrido- [2,3-b] [1, 5] benzodiazepin- (6H) -on-5, deren Salze und Verfahren zu ihrer Herstellung | |
DE1768787C3 (de) | (o-Carboxy-phenyl)-acetamidine, Verfahren zu deren Herstellung und (o-CarboxyphenyO-acetamidine enthaltende Präparate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OI | Miscellaneous see part 1 | ||
OD | Request for examination | ||
AG | Has addition no. |
Ref country code: DE Ref document number: 2611690 Format of ref document f/p: P Ref country code: DE Ref document number: 2543821 Format of ref document f/p: P |
|
D2 | Grant after examination | ||
AG | Has addition no. |
Ref country code: DE Ref document number: 2543821 Format of ref document f/p: P |
|
AG | Has addition no. |
Ref country code: DE Ref document number: 2611690 Format of ref document f/p: P |